Mirati Therapeutics | MRTX - Рыночная капитализация



Рыночная капитализация Изменить Дата
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eisai JPY 1.25T 171.13B 2026-05
Eli Lilly USD 869.02B 146.97B 2026-03
Exelixis USD 14.34B 3.44B 2026-05
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.16B 123M 2026-05
Takeda JPY 8.33T 681.01B 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05